Core Insights - Shanghai continues to be the most concentrated city for multinational company regional headquarters and foreign-funded R&D centers in mainland China [1][5] - The city remains a preferred destination for foreign investment, with significant projects in key industries such as biomedicine, smart manufacturing, and financial services [2][7] Investment and Economic Activity - On July 11, Shanghai awarded certificates to 30 newly recognized multinational company regional headquarters and 15 foreign-funded R&D centers, with a total investment of approximately $3.68 billion (about 263.9 billion RMB) [1] - In the first five months of this year, nearly 2,500 new foreign-funded enterprises were established in Shanghai, with actual foreign investment exceeding $7.6 billion [5] Industry Focus - The newly recognized headquarters and R&D centers primarily come from key development sectors, including biomedicine, smart manufacturing, and fashion consumer goods [2] - The investment projects also cover emerging fields such as digital economy and green low-carbon initiatives [2] Company Strategies - Scopely, a U.S. gaming giant, established its China headquarters in Shanghai, planning to introduce its leading products to the Chinese market by 2026-2027 [3][9] - Sonova, a Swiss hearing care solutions provider, upgraded its China headquarters to a "special zone," indicating a strategic focus on the Chinese market [2][8] Market Potential - The Chinese market is seen as having significant growth potential, particularly in sectors like healthcare and gaming, driven by a large population and increasing demand for innovative products [7][8] - Companies like Baxter Healthcare are increasing local production capabilities to reduce supply chain risks and meet the growing demand in China's healthcare market [7] Talent and Innovation - The gaming industry in China boasts a high density of talent, with approximately 4 million professionals in game development, enhancing the competitive edge of local studios [4] - Companies are leveraging local R&D capabilities and technological advancements, particularly in AI, to improve product quality and development efficiency [4][9]

Group 1 - Wang Yi met with US Secretary of State Rubio to discuss China-US relations and emphasized the need for a pragmatic approach to policy-making [1] - The Chinese side hopes for mutual respect and cooperation to find a new way for China and the US to coexist [1] Group 2 - The Ministry of Finance issued a notice to guide insurance funds for long-term stable investments, establishing a three-year assessment mechanism for state-owned commercial insurance companies [2] - This initiative aims to enhance asset-liability management and investment capabilities, reducing the impact of short-term market fluctuations [2] Group 3 - The Ministry of Industry and Information Technology announced a plan to implement "Artificial Intelligence + Manufacturing" actions, focusing on integrating AI technologies into industrial applications [3] - Guidelines for AI applications in manufacturing will be developed to support enterprises in key scenarios [3] Group 4 - The adjustment of the National Basic Medical Insurance and commercial health insurance drug directories for 2025 has officially started, with a focus on innovative drugs that provide significant clinical value [4] - This initiative aims to enhance the multi-tiered medication security system and meet diverse medication needs [4] Group 5 - The China Securities Association released 28 measures to strengthen self-regulation and promote high-quality development in the securities industry [5][6] - The overall goal is to establish a self-regulatory management system that aligns with the high-quality development of the securities industry [6] Group 6 - The Chinese Foreign Ministry responded to the US request for South Korea to impose restrictions on China, advocating for dialogue and cooperation in trade relations [7] - The Ministry emphasized that any agreements should not harm the interests of third parties [7] Group 7 - The Shanghai and Shenzhen Stock Exchanges issued guidelines for program trading reports for Hong Kong Stock Connect investors, effective from January 12, 2026 [8] - Investors will need to report their trading activities through Hong Kong brokers to the exchanges [8] Group 8 - The Shenzhen Stock Exchange revised the compilation scheme for the ChiNext Composite Index, introducing a monthly removal mechanism for risk-warning stocks [9] - This aims to enhance the index's reliability and reflect market conditions more accurately [9] Group 9 - The US plans to expand a 50% copper tariff to include semi-finished products, which may impact key materials for electric grids and data centers [14] - This move is expected to amplify the market impact of the copper tariffs [14] Group 10 - Guangdong Province launched an AI-assisted imaging system to improve diagnostic quality and efficiency in healthcare [16] - The AI system covers various common examinations and aims to alleviate the workload of medical professionals [16] - The rapid development of the AI healthcare industry in China is noted, with significant advancements in technology and policy support [16]

Core Viewpoint - Guangdong Province has launched an AI-assisted imaging reading system named "Yueyi Zhiying" to enhance diagnostic quality and efficiency while reducing the workload of doctors [1] Group 1: System Overview - The AI-assisted imaging reading system is based on the construction of Guangdong's telemedicine platform [1] - It covers seven common examination types: CT lung nodules, CT bone density, CT pneumonia, CT rib fractures, DR tuberculosis, DR limb fractures, and CT coronary calcium scoring [1]

从2020年开始，太美医疗科技进入自主创新及AI智能化研发阶段，从SaaS升级为数字化平台，打 破组织间壁垒和软件间壁垒，支持跨组织在线协作，从而提升行业整体协调水平。其推出的TrialOS医 药研发协作平台和PharmaOS医学科学营销数字化协作平台，将多种SaaS解决方案和数字化服务相结 合，成功链接医药企业、医院、第三方服务商、医生和患者等多方参与者，显著提升医药研发的整体效 率和商业绩效。 近年来，随着大模型技术的发展，太美医疗科技将AI能力大幅扩展，应用于从新药研发到商业化 的全流程场景，并于今年推出覆盖药品全生命周期的智能服务价值导向型AIaaS合作模式，为生命科学 产业发展提供全栈式智能化支持。太美医疗科技首创"数字员工"体系，将AI智能体嵌入临床研究全流 程，实现从"生产力工具"到"生产力"的突破。 太美医疗科技的战略转型仍在进行中。赵璐表示，公司将继续加大在 AI 技术研发方面的投入，进 一步完善 AIaaS 商业模式并大力拓展国际市场，提升公司在创新医药研发领域的竞争力。 创新药研发面临多重挑战，如临床试验管理流程冗长、跨组织协作效率低下、数据价值挖掘不足 等。太美医疗科技致力于通过AI大 ...

Core Points - The company announced a cash dividend of 0.03 CNY per share (before tax) for its A shares, totaling approximately 18.11 million CNY to be distributed to shareholders [1][2][3] Dividend Distribution Details - The dividend distribution plan was approved at the annual shareholders' meeting held on May 27, 2025 [1] - The record date for the dividend is July 17, 2025, with the last trading day and ex-dividend date both set for July 18, 2025 [2] - The total number of shares used for the dividend calculation is 603,664,264 [2] Taxation Information - For individual shareholders holding shares for over one year, the dividend income is exempt from personal income tax, resulting in a net cash dividend of 0.03 CNY per share [3][5] - For shares held for less than one year, the company will not withhold personal income tax at the time of dividend distribution; tax will be calculated based on the holding period when the shares are sold [3][4] - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld, leading to a net cash dividend of 0.027 CNY per share [5][6]

作者 | 褚杏娟 近日，钉钉企业专属 AI 平台上成功训练出了首个高准确度、高实用性的专业领域大模型——由壹生 检康 (杭州) 生命科技有限公司研发的"豆蔻妇科大模型"，其在专业测试中准确率达 90.2%。 钉钉方面表示，妇科大模型的落地，意味着钉钉生态已经从 SaaS 生态、服务商生态、咨询生态、 交付生态，拓展到 AI 创业者。 与专业医生诊断吻合度达 90.2% 当前，各行各业都在努力将大模型与自身业务场景深度融合，打造行业或专业大模型，实现运营管理 的降本增效。 壹生检康是一家深耕女性精准检测及健康服务的生命科技公司，创业团队大多来自知名互联网企业、 妇产科医疗机构、生物医药公司。基于技术趋势和行业判断，王强宇团队认为，通过训练妇科专业大 模型打造 AI 医生，将有效缓解专业妇科医生、医疗服务不足的难题，对医美机构和女性用户都会带 来巨大的行业和社会价值。 专业性强的"妇科 AI 医生"并不是采用通用大模型就能简单训练出来。启动豆蔻妇科大模型研发以 来，壹生检康团队以开源大模型为基础，通过行业数据训练，第一个版本将模型诊断准确率做到 77.1% 左右。"77.1% 的准确率虽达到行业基础标准，但对于直 ...

Core Insights - A surgical robot trained through video successfully performed a gallbladder removal surgery without human assistance, marking a significant advancement in surgical robotics [1] - This operation was conducted on a patient model and demonstrated the robot's ability to handle unexpected situations with a level of professionalism comparable to skilled human surgeons [1] - The research led by Johns Hopkins University highlights the robot's combination of high precision mechanical systems and human-like adaptability and understanding [1]

Group 1 - Meta has successfully recruited Ruoming Pang, the head of Apple's foundational model team, to lead its newly established "Super Intelligence Lab" (MSL), marking a significant talent acquisition in the AI sector [1] - This move represents a critical case in the ongoing talent competition within the AI field, potentially impacting both Apple and Meta significantly [1] - The competition for top talent in AI is expected to continue evolving, reflecting the increasing importance of AI technology in the tech industry [1] Group 2 - Huawei's gaming center will showcase its HarmonyOS games at the "2025 ChinaJoy," collaborating with popular titles such as Honor of Kings and Plants vs. Zombies 3 [2] - The introduction of Huawei's HarmonyOS games is anticipated to inject new vitality into the gaming industry, which is currently facing intense competition and significant homogenization [2] - This initiative may provide new ideas and directions for the development of the gaming industry [2] Group 3 - AI technology has successfully identified healthy sperm in the semen of a man with a rare condition called azoospermia, using the "STAR system" developed by Columbia University's reproductive center [3] - The system captured over 8 million microscopic images within an hour from a sample that was nearly devoid of sperm, leading to a successful pregnancy for the couple involved [3] - The application of AI in the medical field raises ethical and moral considerations, particularly regarding its role in reproductive health and the need for ensuring the safety and reliability of such technologies [3]

在那些最为疑难的医学问题上，AI 的诊断正确率已经达到 85%，而人类医生只有 20%。 这组数字并不是"画大饼"，而是真实的临床数据——AI 已经在某些极难诊断的场景里，显现出碾压式的实力。 （这是微软介绍最新MAI-DxO系统文章的首图，我很喜欢这个标题，先在这里分享给大家，大概意思就是"通往医疗超级智能之路" 前言 最近，微软在医药领域分享了一组令人震撼的数据： 医学知识和各种案例，就是这样一层一层地在脑子里构建起来。 好医生和一般医生的区别，往往也就是见过更多案例、读过更多论文，学习的东西更多... 而这里面，"读和背"的部分恰好是 AI 最擅长的领域。AI 没有记忆力极限，所有的论文、案例、经验，它都能"烂熟于心"，瞬间调用。 医学属于自然科学，多数情况下，有明确的因果和流程，不像法律那样还涉及人与人的博弈。法律需要斟酌、谈判和权衡，而医学问题更像一道道"选择 题"。 在 "读和背" 这方面，AI 可以不断学习、不断积累知识，逐步实现经验的完美复用。 医学需要大量的专业知识储备 和丰富的案例学习 许多医学生的成长路，是在不停地背诵和实习中走过来的。 大家还记得韩剧《爱在哈佛》里金泰熙饰演的医学生吗？ ...

Group 1 - The core point of the article is that Yongjin Investment intends to make a tender offer to acquire 10% of ST Kelly's total share capital at a price of 5.18 yuan per share [1] - The total number of shares targeted for acquisition is 71.7 million [1] - The tender offer is not aimed at terminating the company's listing status [1] Group 2 - Yongjin Investment will use its own funds to finance the tender offer [1] - A performance guarantee amounting to at least 20% of the total required funds for the tender offer will be deposited into a designated account within two trading days following the announcement of the tender offer [1]